Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.. Daily Stock Analysis

Daily Stock Analysis, VDE, Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California., priceseries

Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.. Daily Stock Analysis
Stock Information
Open
105.94
Close
106.38
High
108.17
Low
103.95
Previous Close
104.73
Daily Price Gain
1.65
YTD High
108.17
YTD High Date
Mar 7, 2022
YTD Low
77.71
YTD Low Date
Jan 3, 2022
YTD Price Change
26.28
YTD Gain
32.81%
52 Week High
108.17
52 Week High Date
Mar 7, 2022
52 Week Low
61.40
52 Week Low Date
Aug 19, 2021
52 Week Price Change
35.94
52 Week Gain
51.03%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Sep 11. 2017
74.27
Oct 6. 2017
79.14
19 Trading Days
6.55%
Link
LONG
Dec 20. 2017
82.37
Jan 29. 2018
89.62
25 Trading Days
8.80%
Link
LONG
Nov 13. 2020
43.35
Nov 30. 2020
47.75
10 Trading Days
10.15%
Link
LONG
Jan 5. 2021
52.25
Jan 21. 2021
56.22
11 Trading Days
7.59%
Link
LONG
Feb 3. 2021
55.46
Feb 26. 2021
61.86
16 Trading Days
11.54%
Link
LONG
Apr 27. 2021
64.93
May 13. 2021
68.59
12 Trading Days
5.64%
Link
LONG
Sep 22. 2021
68.10
Oct 27. 2021
80.79
25 Trading Days
18.63%
Link
LONG
Jan 3. 2022
80.10
Jan 21. 2022
86.55
13 Trading Days
8.05%
Link
Company Information
Stock Symbol
VDE
Exchange
NASDAQ
Company URL
http://www.veracyte.com
Company Phone
(650) 243-6300
CEO
Bonnie H. Anderson
Headquarters
California
Business Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA 94080
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001384101
About

Description

Veracyte, Inc. operates as a molecular diagnostics company in the United States. The company uses genomic technology to resolve diagnostic ambiguity. It offers Afirma Thyroid FNA Analysis solution for use in thyroid cancer diagnosis; cytopathology testing services; and the Afirma Malignancy Classifiers to manage thyroid nodule patients. The company's products also include Percepta Bronchial Genomic Classifier solution for use in lung cancer screening and diagnosis; and Envisia Genomic Classifier solution for idiopathic pulmonary fibrosis. It sells its products through its product specialists, institutional channel managers, account managers, and clinical science specialists. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading